Alcon has acquired Melbourne-based Cylite, known for its hyperparallel optical coherence tomography (HP-OCT) technology.
“We are excited about the potential of this technology in whole-eye OCT imaging and measurement diagnostics and look forward to providing updates in the future on how we are working together to integrate this innovation into our robust eyecare portfolio,” Alcon said in a statement.
Former Cylite New Zealand distributor Cam Gordon said Alcon has been working with Cylite since last year and had an exclusive agreement to license the technology for ophthalmology use. “While I’m disappointed to be losing such a great product from our optometry portfolio so early on, I’m also genuinely thrilled for the shareholders of Cylite and the team who developed the technology. A successful sale is a recognition of their hard work.”
The award-winning device uses novel 3D imaging to provide micron-accurate measurements of the eye, achieving rates of over 300,000 scans per second. The HP-OCT's true-volume images can be used to generate excellent 3D images of the anterior and posterior segments, highly accurate topography maps of the cornea and sclera, plus a full set of biometry parameters, including axial length, Cylite said.
Existing Cylite customers are advised to continue to reach out to their usual point of contact for service and support.
